Literature DB >> 11031202

Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model.

J T Tai1, E E Brooks, S Liang, R Somogyi, J D Rosete, R M Lawn, D Shiffman.   

Abstract

Vascular injury induces extensive alteration to the extracellular matrix (ECM). These changes contribute to lesion formation and promote cell migration and proliferation. To elucidate ECM response to arterial injury, we used real-time polymerase chain reaction monitoring to quantitate the expression levels of 81 genes involved in the synthesis and breakdown of ECM as well as receptors and signaling proteins that communicate and respond to ECM molecules. The temporal regulation of gene expression in the carotid was measured at 1, 3, 5, 7, 9, 14, and 28 days postinjury. Among the 68 genes that showed detectable expression by our method, 47 (69%) were significantly induced or repressed over time, confirming the extensive ECM gene response in this model. More ECM-related genes (31) were regulated at day 1 than at any other time point, and the number of regulated genes decreased over time. However, 14 of the genes were still induced or repressed at day 28, indicating that return to preinjury expression patterns did not occur and no new steady state was achieved over 28 days. In spite of the large number of changes in gene expression, only a small number of expression patterns was observed, suggesting that ECM-related genes could potentially be coregulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11031202     DOI: 10.1161/01.atv.20.10.2184

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries.

Authors:  Minghui Qin; Zhaohui Zeng; Jie Zheng; Prediman K Shah; Stephen M Schwartz; Lawrence D Adams; Behrooz G Sharifi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

2.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.

Authors:  Wenguang Feng; Dongqi Xing; Ping Hua; Yun Zhang; Yiu-Fai Chen; Suzanne Oparil; Edgar A Jaimes
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

4.  Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells.

Authors:  Alexandra Krettek; Galina K Sukhova; Uwe Schönbeck; Peter Libby
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury.

Authors:  Michael Buerke; Markus Guckenbiehl; Hansjörg Schwertz; Ute Buerke; Michael Hilker; Herbert Platsch; Joachim Richert; Sabine Bomm; Guy A Zimmerman; Stephan Lindemann; Ursula Mueller-Werdan; Karl Werdan; Harald Darius; Andrew S Weyrich
Journal:  Biochim Biophys Acta       Date:  2006-05-19

6.  Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach.

Authors:  Ming-Chu Tsai; Li-Fen Shen; Huai-Sheng Kuo; Henrich Cheng; Kin-Fu Chak
Journal:  Mol Cell Proteomics       Date:  2008-05-14       Impact factor: 5.911

7.  Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.

Authors:  Dongqi Xing; Wenguang Feng; Laszlo G Nöt; Andrew P Miller; Yun Zhang; Yiu-Fai Chen; Erum Majid-Hassan; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.